A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients

INTRODUCTION: The Oncotype DX assay was recently reported to predict risk for distant recurrence among a clinical trial population of tamoxifen-treated patients with lymph node-negative, estrogen receptor (ER)-positive breast cancer. To confirm and extend these findings, we evaluated the performance...

Descripción completa

Detalles Bibliográficos
Autores principales: Habel, Laurel A, Shak, Steven, Jacobs, Marlena K, Capra, Angela, Alexander, Claire, Pho, Mylan, Baker, Joffre, Walker, Michael, Watson, Drew, Hackett, James, Blick, Noelle T, Greenberg, Deborah, Fehrenbacher, Louis, Langholz, Bryan, Quesenberry, Charles P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557737/
https://www.ncbi.nlm.nih.gov/pubmed/16737553
http://dx.doi.org/10.1186/bcr1412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557737/
https://www.ncbi.nlm.nih.gov/pubmed/16737553
http://dx.doi.org/10.1186/bcr1412

Ejemplares similares